Morgan Stanley Maintains Underweight on Virtus Inv, Lowers Price Target to $120

Benzinga · 2d ago
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $130 to $120.